KRAS and colorectal carcinoma: Common genetic alterations responsible for the development and progression of CRC include inactivation of the tumor suppressors Adenomatosis polyposis coli (APC) (~ 70%) and TP53 (~ 60%) and mutational activation of KRAS (~ 40%) [2–7].